Moderna said Tuesday that a new lab study shows its COVID-19 vaccine should provide protection against emerging mutations of the CCP (Chinese Communist Party) virus, including the highly contagious Delta variant that has health officials on edge.
In vitro neutralization studies of blood obtained from eight people one week after they were vaccinated with their second dose of Moderna’s vaccine, mRNA-1273, show the product provoked an antibody response against all the virus variants tested, the company said in a release.
